Magazine
Latest Issue

Gene trade

Patent laws were designed to protect actual inventions, not discoveries of natural phenomena. Patenting the human gene is challenging that rule. This is not in the public interest

By John Maddox   March 1996

Are there any circumstances in which a private citizen, a public institute or a corporation can legitimately hold a patent on a human gene? All patent laws refuse protection to discoveries about the natural world; Columbus could not have patented America. But genetics has become so competitive and potentially profitable that researchers (or, more often, their corporate sponsors) are nibbling away at the spirit, if not the letter, of the law. The distinction between discovery and invention is becoming blurred.

There was a spectacular illustration of this four years ago, when the US National Institutes of Health, on behalf of…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to letters@prospect-magazine.co.uk

More From Prospect